Company / R&D per Share
BioXcel Therapeutics, Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$9.75
FY2025
5-year range
$1.88 / $45.07
FY2022-FY2025
Trend
-78.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $3.24 to $9.75 over the past 2 years.
Based on SEC 10-K filings.
9.75 in FY2025 with a 3-year CAGR of +73.0%.
Improved from $3.24 to $9.75 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +73.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 78.4% year-over-year.
Company context
Key Data Points
- Altman Z-Score -17.49 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.75 | -78.4% |
| FY2024 | $45.07 | +1290.4% |
| FY2023 | $3.24 | +72.1% |
| FY2022 | $1.88 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026